Trial Profile
A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safety and Efficacy of Botulax Versus Botox in Treatment of Post Stroke Upper Limb Spasticity
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Letibotulinumtoxina (Primary)
- Indications Muscle spasticity; Stroke
- Focus Therapeutic Use
- Sponsors Hugel
- 13 Aug 2015 New trial record